首页> 外国专利> POLYPEPTIDE OF MPL LIGAND (VARIANTS), ISOLATED MOLECUL OF NUCLEIC ACID ENCODING POLYPEPTIDE OF MPL LIGAND (VARIANTS), EXPRESSING VECTOR, HOST CELL, METHOD FOR MANUFACTURING POLYPEPTIDE OF MPL LIGAND (VARIANTS), COMPOSITION, METHOD FOR DRUG MANUFACTURING, METHOD FOR DETECTING POLYPEPTIDE OF MPL LIGAND, ANTIBODY, METHOD FOR PRODUCING ANTIBODY, HYBRIDOMA CELL LINE

POLYPEPTIDE OF MPL LIGAND (VARIANTS), ISOLATED MOLECUL OF NUCLEIC ACID ENCODING POLYPEPTIDE OF MPL LIGAND (VARIANTS), EXPRESSING VECTOR, HOST CELL, METHOD FOR MANUFACTURING POLYPEPTIDE OF MPL LIGAND (VARIANTS), COMPOSITION, METHOD FOR DRUG MANUFACTURING, METHOD FOR DETECTING POLYPEPTIDE OF MPL LIGAND, ANTIBODY, METHOD FOR PRODUCING ANTIBODY, HYBRIDOMA CELL LINE

机译:MPL配体(变体)的多肽,编码MPL配体(变体)的多肽的核酸分离分子,表达载体,宿主细胞,MPL配体(变体)的多肽的制备方法,组成,制备方法,药物制备方法MPL抗体抗体的制备方法,抗体,杂交细胞株的制备

摘要

Isolated thrombopoietin (TPO), isolated DNA encoding TPO, and recombinant or synthetic methods of preparing and purifying TPO are disclosed. Various forms of TPO are shown to influence the replication, differentiation or maturation of blood cells, especially megakaryocytes and megakaryocyte progenitor cells. Accordingly, these compounds may be used for treatment of thrombocytopenia.
机译:公开了分离的血小板生成素(TPO),编码TPO的分离DNA以及制备和纯化TPO的重组或合成方法。已显示各种形式的TPO影响血细胞,尤其是巨核细胞和巨核祖细胞的复制,分化或成熟。因此,这些化合物可用于治疗血小板减少症。

著录项

  • 公开/公告号UA72869C2

    专利类型

  • 公开/公告日2005-05-16

    原文格式PDF

  • 申请/专利权人 GENETECH INC;

    申请/专利号UA19960072627

  • 发明设计人

    申请日1994-12-28

  • 分类号A61K38/19;C12N15/19;

  • 国家 UA

  • 入库时间 2022-08-21 22:16:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号